Challenges in studying COVID-19 treatments in real-world hospital datasets: A case study of tocilizumab

被引：0
|
作者：
Owen, Ruth [1 ]
Qizilbash, Nawab [2 ]
Pocock, Stuart [1 ]
Mendez, Ignacio [2 ]
Diaz, Sara Velazquez [3 ]
Vazquez, Jose Maria Castellano [4 ]
机构：
[1] London Sch Hyg & Trop Med, London, England
[2] Oxon Epidemiol, Madrid, Spain
[3] Univ CEU San Pablo, Madrid, Spain
[4] Univ San Pablo CEU, Madrid, Spain
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
下载
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [31] Considerations and Challenges for Real-World Deployment of an Acoustic-Based COVID-19 Screening System
    Grant, Drew
    McLane, Ian
    Rennoll, Valerie
    West, James
    SENSORS, 2022, 22 (23)
  • [32] Real-world evidence of the use of glucocorticoids for severe COVID-19
    Albarran-Sanchez, Alejandra
    Ramirez-Renteria, Claudia
    Mercado, Moises
    Sanchez-Garcia, Miriam
    de Jesus Barrientos-Flores, Corazon
    Ferreira-Hermosillo, Aldo
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [33] Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination
    Rubin, Eric J.
    Baden, Lindsey R.
    Morrissey, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08): : E40 - E40
  • [34] Real-World Effectiveness of Four Types of COVID-19 Vaccines
    Abdel-Qader, Derar H.
    Abdel-Qader, Hasan
    Silverthorne, Jennifer
    Kongkaew, Chuenjid
    Meslamani, Ahmad Z. Al
    Hayajneh, Wail
    Alwahadneh, Adel M.
    Hamadi, Salim
    Abu-Qatouseh, Luay
    Awad, Riad
    Al Nsour, Mohannad
    Alhariri, Abdallah
    Shnewer, Khaldoun
    Da'ssan, Mohammad
    Obeidat, Nathir M.
    Nusair, Khaldoon E.
    Jalamdeh, Mothafer S.
    Hawari, Feras
    Asad, Mohammad
    AbuRuz, Salah
    VACCINES, 2023, 11 (05)
  • [35] COVID-19 pandemic: Real-world experiences and lessons learned
    Srijithesh, P. R.
    Hakim, Shakir H.
    INTERVENTIONAL NEURORADIOLOGY, 2021, 27 (1_SUPPL) : 36 - 38
  • [36] Evaluation of favipiravir in the treatment of COVID-19 based on the real-world
    Deng, Weishang
    Yang, Changyuan
    Yang, Sensen
    Chen, Haitao
    Qiu, Zhikun
    Chen, Jisheng
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (04) : 555 - 565
  • [37] In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study
    Angermair, Stefan
    Hardenberg, Jan-Hendrik
    Rubarth, Kerstin
    Balzer, Felix
    Akbari, Nilufar
    Menk, Mario
    Spies, Claudia
    Eckardt, Kai-Uwe
    Poddubnyy, Denis
    Siegmund, Britta
    Schneider, Thomas
    Treskatsch, Sascha
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series
    McKenzie, Matt G.
    Lee, Yeunju
    Mathew, Julin
    Anderson, Megan
    Vo, Alison T.
    Akinyele, Samuel
    Narayanan, Malarvizhi
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (04) : 587 - 592
  • [39] Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study
    Lakatos, Botond
    Szabo, Balint Gergely
    Bobek, Ilona
    Kiss-Dala, Noemi
    Gaspar, Zsofia
    Riczu, Alexandra
    Petrik, Borisz
    Farkas, Balazs Ferenc
    Sebestyen, Gabriella
    Gopcsa, Laszlo
    Sinko, Janos
    Remenyi, Peter
    Szlavik, Janos
    Mathiasz, Dora
    Valyi-Nagy, Istvan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 125 : 233 - 240
  • [40] A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities
    Jiao, Xiaofei
    Wang, Ya
    Liu, Dan
    Zeng, Shaoqing
    Chi, Jianhua
    Li, Ruyuan
    Yu, Yang
    Yu, Ruidi
    Wang, Siyuan
    Yuan, Yuan
    Gao, Yue
    Xu, Sen
    Li, Chunrui
    Gao, Qinglei
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (08):
12345